Ogawa K, Miura K, Katsube T, Wagatsuma Y, Konno S, Wakasugi S, Watanabe T, Shimakawa T, Ishikawa S, Naritaka Y
Dept. of Surgery, Tokyo Women's Medical College Daini Hospital.
Gan To Kagaku Ryoho. 1995 Aug;22(9):1191-6.
Pyrimidine nucleoside phosphorylase (PyNPase) activity was measured in gastric cancer tissue from 25 patients who underwent resections of gastric cancer. The relation between the activity and host and tumor factors in gastric cancer was studied, and the following results were obtained. 1. PyNPase activity was 128.3 +/- 99.5 in cancer tissue and 37.2 +/- 23.1 in non-cancer tissue. The level was significantly higher in cancer tissue (p < 0.0001). 2. With respect to host factors, the PyNPase activity tended to be high in patients in whom cell-mediated immune response was maintained. 3. With respect to tumor factors, the values tended to be high in patients who were positive for lymph vessel and venous invasion, and positive for lymph node metastasis. 5'-deoxy-5-fluorouridine(5'-DFUR) is an anticancer agent which manifests antitumor effects when it is transformed into 5-FU by PyNPase. When this agent is administered to gastric cancer patients, it can be expected to be more effective in the above types of patients because of its characteristics.
对25例接受胃癌切除术患者的癌组织进行嘧啶核苷磷酸化酶(PyNPase)活性检测。研究了该活性与胃癌患者宿主及肿瘤因素之间的关系,结果如下:1. 癌组织中PyNPase活性为128.3±99.5,非癌组织中为37.2±23.1。癌组织中的活性水平显著更高(p<0.0001)。2. 关于宿主因素,细胞介导免疫反应维持较好的患者中PyNPase活性往往较高。3. 关于肿瘤因素,淋巴管和静脉侵犯阳性及淋巴结转移阳性的患者中该值往往较高。5'-脱氧-5-氟尿苷(5'-DFUR)是一种抗癌药物,经PyNPase转化为5-氟尿嘧啶(5-FU)时发挥抗肿瘤作用。由于其特性,将该药物用于胃癌患者时,预计在上述类型患者中更有效。